Takashima T, Nishimura S, Kawajiri H, Mizuyama Y, et al. An Exploratory Phase II Study of Eribulin Re-challenge After Short Term Therapy of 5-Fluorouracil for HER2 Negative, Advanced or Recurrent Breast Cancer. Anticancer Res 2021;41:5007-5014.
PMID: 34593449